Literature DB >> 18246126

PML enhances the regulation of p53 by CK1 in response to DNA damage.

O Alsheich-Bartok1, S Haupt, I Alkalay-Snir, S Saito, E Appella, Y Haupt.   

Abstract

In response to stress, p53 is accumulated and activated to induce appropriate growth inhibitory responses. This requires the release of p53 from the constraints of its negative regulators Mdm2 and Mdm4. A key event in this dissociation is the phosphorylation of p53 at threonine residue (Thr18) within the Mdm2/4-binding domain. Casein kinase 1 (CK1) plays a major role in this phosphorylation. The promyelocytic leukemia protein (PML) regulates certain modifications of p53 in response to DNA damage. Here, we investigated the role of PML in the regulation of Thr18 phosphorylation. We found that PML enhances Thr18 phosphorylation of endogenous p53 in response to stress. On DNA damage, CK1 accumulates in the cell, with a proportion concentrated in the nucleus together with p53 and PML. Furthermore, CK1 interacts with endogenous p53 and PML, and this interaction is enhanced by genotoxic stress. Inhibition of CK1 impairs the protection of p53 by PML from Mdm2-mediated degradation. Our findings support a role for PML in the regulation of p53 by CK1. We propose that following DNA damage, PML facilitates Thr18 phosphorylation by recruiting p53 and CK1 into PML nuclear bodies, thereby protecting p53 from inhibition by Mdm2, leading to p53 activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18246126     DOI: 10.1038/sj.onc.1211036

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

1.  PML: An emerging tumor suppressor and a target with therapeutic potential.

Authors:  Erin L Reineke; Hung-Ying Kao
Journal:  Cancer Ther       Date:  2009-09-01

2.  Loss of PML cooperates with mutant p53 to drive more aggressive cancers in a gender-dependent manner.

Authors:  Sue Haupt; Catherine Mitchell; Vincent Corneille; Jake Shortt; Stephen Fox; Pier Paolo Pandolfi; Mireia Castillo-Martin; Dennis M Bonal; Carlos Cordon-Cardo; Guillermina Lozano; Ygal Haupt
Journal:  Cell Cycle       Date:  2013-05-08       Impact factor: 4.534

Review 3.  The role of PML in the control of apoptotic cell fate: a new key player at ER-mitochondria sites.

Authors:  P Pinton; C Giorgi; P P Pandolfi
Journal:  Cell Death Differ       Date:  2011-04-08       Impact factor: 15.828

4.  Seed-expressed casein kinase I acts as a positive regulator of the SeFAD2 promoter via phosphorylation of the SebHLH transcription factor.

Authors:  Mi Jung Kim; Young Sam Go; Saet Buyl Lee; Youn Sung Kim; Jeong Sheop Shin; Myung Ki Min; Inhwan Hwang; Mi Chung Suh
Journal:  Plant Mol Biol       Date:  2010-03-28       Impact factor: 4.076

5.  Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53.

Authors:  Caroline J DeHart; David H Perlman; S J Flint
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

6.  DNA damage induces the accumulation of Tiam1 by blocking β-TrCP-dependent degradation.

Authors:  Guixin Zhu; Zhongyun Fan; Miao Ding; Libing Mu; Juan Liang; Yajie Ding; Yu Fu; Binlu Huang; Wei Wu
Journal:  J Biol Chem       Date:  2014-04-15       Impact factor: 5.157

Review 7.  TRIMming p53's anticancer activity.

Authors:  S Elabd; G Meroni; C Blattner
Journal:  Oncogene       Date:  2016-02-22       Impact factor: 9.867

Review 8.  Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).

Authors:  Pengfei Xu; Chiara Ianes; Fabian Gärtner; Congxing Liu; Timo Burster; Vasiliy Bakulev; Najma Rachidi; Uwe Knippschild; Joachim Bischof
Journal:  Gene       Date:  2019-07-31       Impact factor: 3.688

9.  A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection.

Authors:  Nicola J MacLaine; Bodil Oster; Bettina Bundgaard; Jennifer A Fraser; Carolyn Buckner; Pedro A Lazo; David W Meek; Per Höllsberg; Ted R Hupp
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

10.  Compound In Vivo Inactivation of Pml and p53 Uncovers a Functional Interaction in Angiosarcoma Suppression.

Authors:  Antonella Papa; Carlos Cordon-Cardo; Rosa Bernardi; Pier Paolo Pandolfi
Journal:  Genes Cancer       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.